Aquavit Pharmaceuticals, a private US-based life science company, has announced the appointment of David Goldberg as chief medical officer.
Dr Goldberg (pictured) is a dermatologist recognized internationally for his work with skin lasers, cosmetic dermatology and facial rejuvenation techniques.
Prior to joining Aquavit, Dr Goldberg served as President of ASLMS and was on the Board of Directors of AAD, ASLMS and ASDS. Additionally, Dr Goldberg is a Clinical Professor of Dermatology and Director of Laser Research at Mount Sinai School of Medicine, a Clinical Professor of Dermatology and Chief of Dermatologic Surgery at Rutgers New Jersey Medical School and the Chief of Dermatology at Hackensack University Medical Center.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze